Guo Jiale, Peng Caiju, Hu Ziyan, Li Yehai
Department of Orthopedics, Chaohu Hospital of Anhui Medical University, Hefei, China.
Front Surg. 2022 Sep 29;9:978798. doi: 10.3389/fsurg.2022.978798. eCollection 2022.
Proximal humeral fractures are the third most common fracture in the body, and their incidence is rising year by year as the population ages. However, the treatment of the proximal humerus in parts 3 and 4 is still debatable, necessitating a network meta-analysis to determine the best treatment for each treatment modality.
We searched PubMed, Embase, Cochrane Library for randomized controlled trials on proximal humeral fractures up to June 21, 2022. We performed data extraction and literature quality assessment by two independent authors and extracted constant score and reoperation rate as indicators for evaluation. Stata software, Revman software, JAGS software and the R-based BlandAltmanLeh package, gemtc package and riags package were used to perform this Bayesian network meta-analysis.
Following screening, 11 papers with a total of 648 participants were included in the analysis. The SUCRA values for the constant score were in the following order: RSA, IMN, Conservative, HA, and LP, and the SUCRA values for the reoperation rate were LP, HA, IMN, Conservative, and RSA.
The elderly with 3- or 4-part proximal humeral fractures should consider RSA because it received the best evaluation ranking in terms of constant score and reoperation rate.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022341209, identifier: CRD42022341209.
肱骨近端骨折是身体中第三常见的骨折,随着人口老龄化,其发病率逐年上升。然而,肱骨近端3、4部分骨折的治疗仍存在争议,因此需要进行网状Meta分析来确定每种治疗方式的最佳治疗方法。
我们检索了PubMed、Embase、Cochrane图书馆,以获取截至2022年6月21日关于肱骨近端骨折的随机对照试验。由两名独立作者进行数据提取和文献质量评估,并提取恒定评分和再次手术率作为评估指标。使用Stata软件、Revman软件、JAGS软件以及基于R的BlandAltmanLeh包、gemtc包和riags包进行这项贝叶斯网状Meta分析。
经过筛选,共纳入11篇论文,总计648名参与者。恒定评分的SUCRA值顺序如下:RSA、IMN、保守治疗、HA、LP;再次手术率的SUCRA值顺序为:LP、HA、IMN、保守治疗、RSA。
肱骨近端3或4部分骨折的老年人应考虑RSA,因为就恒定评分和再次手术率而言,它获得了最佳评估排名。
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022341209,标识符:CRD42022341209。